July 9, 2021
Dr. Martin is Chairman of M-CAM International Innovation Risk Management, the world’s largest underwriter of intangible assets used in finance, in 168 countries.
From Martin’s introductory remarks:
In the majority of the countries around the world are underwriting systems which include the entire corpus of all patents, patent applications, federal grants, procurement records, E-government records, etc. We have the ability to not only track what is happening and who is involved in what’s happening, but we monitor a series of thematic interests for a variety of organizations and individuals, as well as for our own commercial use because, as you probably know, we maintain three global Equity indices which are the top performing large-cap and mid-cap equity indexes worldwide. So our business is to monitor the innovation that’s happening around the world, and specifically to monitor the economics of that innovation, the degree to which, you know, financial interests are being served, corporate interests are being dislocated, etc. So, our business is the business of innovation, and its finance.
“The tragedy is, we’re now sitting in a world where we have hundreds of millions of people who are being injected with a pathogen stimulating computer sequence which is being sold under what the patent office, what the medical profession, and what the FDA in its own clinical standards would not suggest is a vaccine, but by using the term, we actually are now subjecting hundreds of millions of people to what was known to be by 2005, a biological weapon.”